Area: Cardiology
Location: Online, Virtual
Date: August 29 to September 1
2020 ESC Guidelines on Adult Congenital Heart Disease
EXPLORER-HCM: Efficacy and Safety of Mavacamten in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy
IMPACT-Afib Implementation of Stroke Prevention in Atrial Fibrillation
Tackling cardiovascular diseases with a new generation of polypills
ESC Gold Medal 2020 Winner: Kari Stefansson
ESC Gold Medal 2020 Winner: Stefanie Dimmeler
PCSK9 inhibitors from bench to real world: a journey to improve CV outcomes in very high-risk patients
BRACE CORONA: Continuing vs. Suspending ACE Inhibitors and ARBs in COVID-19
2021 ESC Guidelines on Sports Cardiology and Exercise in Patients with Cardiovascular Disease
LoDoCo2 Low-Dose Colchicine in Coronary Disease
HOME-PE - Hospitalisation or Outpatient Management of PE Patients - HESTIA vs. Simplified PESI
ESC 2020: Best clinical cases - Awards session
Persistence and cardiovascular outcomes with ramipril, atorvastatin, ASA as a single pill compared to the multi pill combination. A subanalysis of the START study, a claims data analysis
PARALLAX: Sacubitril/Valsartan versus Individualized RAAS Blockade in Patients with HFpEF
Time to reduce the implementation gaps-the role of PCSK9i in routine practice
BPLTTC - Blood Pressure Lowering for Prevention of Cardiovascular Events across Different Levels of Blood Pressure
Big babies could be at higher risk of common heart rhythm disorder in adulthood
Risk of heart complications after major surgery is higher than previously thought
Revision of the Guidelines on Myocardial Revascularization - EACTS/ESC joint statement
Stephan Achenbach became the new president of ESC
Summary of the ESC Congress 2020
The ESC Congress 2020 has started
EuroPCR 2020 cancelled due to COVID-19
ESC Congress 2020 goes Virtual